PrandiMet - 0169-0093-21 - (repaglinide and metformin hydrochloride)

Alphabetical Index


Drug Information of PrandiMet

Product NDC: 0169-0093
Proprietary Name: PrandiMet
Non Proprietary Name: repaglinide and metformin hydrochloride
Active Ingredient(s): 500; 1    mg/1; mg/1 & nbsp;   repaglinide and metformin hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of PrandiMet

Product NDC: 0169-0093
Labeler Name: Novo Nordisk
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022386
Marketing Category: NDA
Start Marketing Date: 20090116

Package Information of PrandiMet

Package NDC: 0169-0093-21
Package Description: 1 BOTTLE, PLASTIC in 1 CARTON (0169-0093-21) > 20 TABLET in 1 BOTTLE, PLASTIC

NDC Information of PrandiMet

NDC Code 0169-0093-21
Proprietary Name PrandiMet
Package Description 1 BOTTLE, PLASTIC in 1 CARTON (0169-0093-21) > 20 TABLET in 1 BOTTLE, PLASTIC
Product NDC 0169-0093
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name repaglinide and metformin hydrochloride
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20090116
Marketing Category Name NDA
Labeler Name Novo Nordisk
Substance Name METFORMIN HYDROCHLORIDE; REPAGLINIDE
Strength Number 500; 1
Strength Unit mg/1; mg/1
Pharmaceutical Classes Glinide [EPC],Potassium Channel Antagonists [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]

Complete Information of PrandiMet


General Information